Study: OTOF Gene Therapy Restored Hearing in Deaf Patients
In a new study, gene therapy targeting the OTOF gene significantly restored hearing in children and adults with congenital deafness, with rapid improvement and no serious side effects.
In a new study, gene therapy targeting the OTOF gene significantly restored hearing in children and adults with congenital deafness, with rapid improvement and no serious side effects.
Decibel Therapeutics announced a partnership with Invitae, a medical genetics company, to launch Amplify, a no-charge genetic testing program to screen for the genetic cause of congenital hearing loss in children diagnosed with auditory neuropathy.